GKB Ophthalmics Ltd.
Snapshot View

81.75 +3.75 ▲4.8%

16 August 2022, 04:01:00 PM
Volume: 14,477

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Medical Equipment/Supplies/Accessories Compare with Industry peers
Website http://www.gkb.net
Market Cap 41.21 Cr.
Enterprise Value(EV) 34.67 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 2.53 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 32.34 Trailing Twelve Months Ending 2022-03
Industry PE 44.77 Trailing Twelve Months Ending 2022-03
Book Value / Share 127.97 Trailing Twelve Months Ending 2022-03
Price to Book Value 0.64 Calculated using Price: 81.75
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 0.50 Cr. 5,040,580 Shares
FaceValue 10
Company Profile
The Company is engaged in the business of manufacturing and supply of semi - finished plastic lenses. It has manufacturing facilities at Tivim Industrial Estate, Mapusa - Goa.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+4.81%
1 Week
+4.54%
1 Month
+2.19%
3 Month
6 Month
-7.68%
1 Year
-13.99%
2 Year
+40.95%
5 Year
-36.87%
10 Year
+108.81%
9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) -3.10 6.60 -3.30 9.32 5.65 -2.12 -2.52 -4.41 -2.25
Return on Capital Employed (%) 3.36 14.52 0.82 18.94 7.99 0.25 -0.34 -1.38 0.65
Return on Assets (%) -1.52 3.39 -1.78 5.48 3.34 -1.15 -1.36 -2.41 -1.29

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 35 40 40 45 47 45 55 59 63 63
Non Curr. Liab. 4 3 2 2 2 2 5 5 2 3
Curr. Liab. 34 30 33 23 37 36 37 41 38 40
Minority Int. 4 4
Equity & Liab. 73 73 75 69 86 83 97 106 107 110
Non Curr. Assets 27 29 29 18 19 19 33 33 33 35
Curr. Assets 45 43 46 51 66 64 64 73 74 76
Misc. Exp. not W/O
Total Assets 73 73 75 69 86 83 97 106 107 110

Profit Loss View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. TTM
Net Sales 43 41 35 44 74 77 57 59 57 71
Other Income 1 1 1 2 1 0 2 1 2 1
Total Income 43 42 36 46 75 78 59 59 59 72
Total Expenditure -40 -34 -34 -46 -72 -76 -56 -56 -55 -66
PBIDT 4 8 1 0 3 2 3 3 4 6
Interest -3 -3 -3 -2 -1 -1 -1 -1 -2 -1
Depreciation -1 -1 -2 -1 -1 -2 -4 -4 -3 -3
Taxation 0 -2 1 -4 0 0 0 0
Exceptional Items -1 0 1 11 3 -1
PAT -1 2 -1 4 3 -1 -1 -2 -1 2
Minority Interest 0 -1
Share Associate 0 2 1 0 1 1 0
Other Related Items 0
Consolidated Net Profit -1 4 4 3 -1 -1 -2 -1 1
Adjusted EPS -2 10 0 10 6 -2 -2 -4 -2 3

Cash Flow View Details >>

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 3 3 6 7 -11 -3 -3 4 3 -4
Cash Fr. Inv. -5 -2 -2 -1 15 4 1 -10 -4 -6
Cash Fr. Finan. 2 -1 -5 -6 -3 -1 1 13 4 3
Net Change 0 1 0 1 0 -1 0 7 4 -7
Cash & Cash Eqvt 2 2 2 3 3 2 2 9 13 6

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 48.98 49.04 49.52 59.44 59.24 59.58 59.69 59.72 59.73
Public 51.02 50.96 50.48 40.56 40.76 40.42 40.31 40.28 40.27
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Tue, 16 Aug 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find attached copies of newspaper cuttings of the extract of Statement of Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30 2022 published in The Financial Express (Mumbai Edition) and on Pudhari (Marathi) dated August 14 2022.Please acknowledge receipt.
Fri, 12 Aug 2022
Board Meeting Outcome for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30 2022.
The meeting of the Board of Directors of the Company was held on August 12 2022 which considered and took on record the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 2022. Pursuant to Regulation 33 (3) (d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 enclosed please find the following :1. Standalone Financial Results for the quarter ended June 30 2022 together with the Limited Review Report.2. Consolidated Financial Results for the quarter ended June 30 2022 along with Limited Review Report.The above Unaudited Financial Results and the Limited Review Reports are available on the Companys website www.gkb.net and on the BSE website www.bseindia.com
Fri, 12 Aug 2022
Statement Of Deviation(S) Or Variation(S) Under Regulation 32 Of SEBI ( Listing Obligations And Disclosure Requirements ) Regulations 2015
Pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 read with SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24 2019 we would like to inform you that the Audit Committee in their meeting held on August 12 2022 has reviewed the utilisation of funds which were raised by means of preferential allotment and noted that there is no deviation or variation in the use of proceeds during the quarter ended June 30 2022. Enclosed please find the Statement as per the format giving details of the same.Kindly take the information on records.

Technical Scans View Details >>

Fri, 12 Aug 2022
High Delivery Percentage High Delivery Percentage
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Close Crossing 50 SMA From Below Close Crossing 50 SMA From Below
Close Crossing 20 EMA From Below Close Crossing 20 EMA From Below
RSI Trending Up RSI Trending Up

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 219,167.25 914.60 +0.1%
Divi's Laboratories Ltd. 98,918.90 3,732.00 +0.2%
Cipla Ltd. 82,906.37 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. 70,920.35 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. 62,010.73 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. 51,917.53 1,569.90 +2.0%
Piramal Enterprises Ltd. 45,855.65 1,926.70 +0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.35 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 33.43 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-06 33.32 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.69 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 70.15 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 64.82 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-06 24.38 1,926.70 +0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.37 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8.44 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-06 3.86 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.50 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.43 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.12 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-06 1.28 1,926.70 +0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 0.04 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-03 1.56 1,926.70 +0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,926.70 +0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,926.70 +0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-03 13,993.30 1,926.70 +0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-03 1,345.89 1,926.70 +0.3%

FAQ's On GKB Ophthalmics Ltd.

Can I Buy GKB Ophthalmics Shares now?

What is the Share Price of GKB Ophthalmics?

What is the Relative Strength Index (RSI) Value of GKB Ophthalmics?

What is the Market Capital (MCAP) of GKB Ophthalmics?

What are the key metrics to analyse GKB Ophthalmics?

What is the Price Performance of GKB Ophthalmics?